They have found that the CB2 Q63R variant correleted with severity of NASH, suggesting that CB2 Q63R variant has a critical role in modulating hepatic inflammation state, and the liver damage (43). This evidence concerns the gene CNR2 and metabolic dysfunction-associated steatohepatitis.